SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000889812-98-000733
Filing Date
1998-03-26
Accepted
1998-03-26 00:00:00
Documents
12
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT 10-K 251672
2 EMPLOYMENT AGREEMENT EX-10.25 48928
3 CONSENT OF INDEPENDENT ACCOUNTS EX-23.1 766
4 CONSENT OF ERNST & YOUNG LLP EX-23.2 892
5 POWER OF ATTORNEY EX-24 11076
6 FINANCIAL DATA SCHEDULE EX-27.1 2575
7 FINANCIAL DATA SCHEDULE EX-27.2 2393
8 FINANCIAL DATA SCHEDULE EX-27.3 2161
9 FINANCIAL DATA SCHEDULE EX-27.4 2615
10 FINANCIAL DATA SCHEDULE EX-27.5 2598
11 FINANCIAL DATA SCHEDULE EX-27.6 2659
12 FINANCIAL DATA SCHEDULE EX-27.7 2619
  Complete submission text file 0000889812-98-000733.txt   333483
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19034 | Film No.: 98574754
SIC: 2834 Pharmaceutical Preparations